T/QMIS 003-2022 Active Group standards

T/QMIS 003-2022 Determination of Quinolone Drugs in Seawater by Liquid Chromatography-Tandem Mass Spectrometry

T/QMIS 003-2022 Determination of Quinolone Drugs in Seawater by Liquid Chromatography-Tandem Mass Spectrometry

Publish Date: 2022-10-12 Implement Date: 2022-10-12 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/QMIS 003-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: \nChemical testing of water
Publish Date: 2022-10-12
Implement Date: 2022-10-12

Scope

Main technical content: This method specifies the sampling, processing, analysis steps, result calculation, quality assurance, and quality control methods and procedures for determining the residual amounts of 17 quinolone drugs in seawater by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). This method is suitable for determining the residual amounts of enoxacin, marbofloxacin, ofloxacin, pefloxacin, florfenicol, lomefloxacin, norfloxacin, ciprofloxacin, orbifloxacin, enrofloxacin, danofloxacin, sarafloxacin, sparfloxacin, difloxacin, oxolinic acid, and florfenicol in seawater, either individually or in combination. The detection limit for quinolone drugs in seawater is 5.0 ng/L, and the quantification limit is 20 ng/L.

Development Information

Related Standards

Contact Us